GB1145623A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB1145623A
GB1145623A GB1037666A GB1037666A GB1145623A GB 1145623 A GB1145623 A GB 1145623A GB 1037666 A GB1037666 A GB 1037666A GB 1037666 A GB1037666 A GB 1037666A GB 1145623 A GB1145623 A GB 1145623A
Authority
GB
United Kingdom
Prior art keywords
acceptable salt
physiologically acceptable
compositions
march
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1037666A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUSTACE CECIL BARTON WRIGHT
Original Assignee
EUSTACE CECIL BARTON WRIGHT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUSTACE CECIL BARTON WRIGHT filed Critical EUSTACE CECIL BARTON WRIGHT
Priority to GB1037666A priority Critical patent/GB1145623A/en
Publication of GB1145623A publication Critical patent/GB1145623A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,145,623. Pharmaceutical compositions. E. C. BARTON-WRIGHT. 9 March, 1967 [9 March, 1966], No. 10376/66. Heading A5B. A pharmaceutical composition for the treatment of osteo- and rheumatoid-arthritis consists essentially of the active ingredients dpantothenic acid or a physiologically acceptable salt thereof e.g. the Na or Ca salts, and cysteine or cystine (or a physiologically acceptable salt of either, e.g. the hydrochloride). Modified compositions may also contain queen bee substance ("royal jelly"), ethyl n-heptyloxyacetate or 10-hydroxy-#<SP>2</SP>-decenoic acid or a physiologically acceptable salt thereof. The compositions may be administered orally in the form of tablets, capsules or dragees which may be enteric coated, parenterally from dry ampoules and from ampoules and multidose flasks containing pyrogen-free water, aqueous polyvinylpyrrolidone or arachis oil as a carrier, and rectally as suppositories.
GB1037666A 1966-03-09 1966-03-09 Pharmaceutical composition Expired GB1145623A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1037666A GB1145623A (en) 1966-03-09 1966-03-09 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1037666A GB1145623A (en) 1966-03-09 1966-03-09 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB1145623A true GB1145623A (en) 1969-03-19

Family

ID=9966712

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1037666A Expired GB1145623A (en) 1966-03-09 1966-03-09 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB1145623A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2198942A (en) * 1985-11-27 1988-06-29 Senju Pharma Co Therapeutic composition for diabetic complications
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
WO2001019359A2 (en) * 1999-09-16 2001-03-22 Britannia Pharmaceuticals Limited Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
US8906966B2 (en) 2006-07-13 2014-12-09 Paul Sherwood Medicaments containing panthenol
US10004711B2 (en) 2014-05-08 2018-06-26 Dsm Ip Assets B.V. Methods and compositions comprising 10-hydroxy-2-decenoic acid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2198942A (en) * 1985-11-27 1988-06-29 Senju Pharma Co Therapeutic composition for diabetic complications
GB2198942B (en) * 1985-11-27 1990-07-11 Senju Pharma Co Therapeutic composition for diabetic complications
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
WO2001019359A2 (en) * 1999-09-16 2001-03-22 Britannia Pharmaceuticals Limited Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
WO2001019359A3 (en) * 1999-09-16 2002-10-03 Britannia Pharmaceuticals Ltd Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
US8614249B2 (en) 1999-09-16 2013-12-24 Prototype Bioforum Ltd. Medicaments containing pantothenic acid
US8906966B2 (en) 2006-07-13 2014-12-09 Paul Sherwood Medicaments containing panthenol
US10004711B2 (en) 2014-05-08 2018-06-26 Dsm Ip Assets B.V. Methods and compositions comprising 10-hydroxy-2-decenoic acid

Similar Documents

Publication Publication Date Title
GB1277132A (en) Pyridobenzo-diazepine derivatives
ES8105746A1 (en) (N-phosphonoacetyl-L-aspartato) (1,2 diaminocyclohexane) platinum (II) and the sodium, potassium or lithium salts thereof, their preparation and pharmaceutical compositions containing them.
GB1145623A (en) Pharmaceutical composition
GB1422193A (en) Pharmaceutical compositions
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
IL65787A (en) Antiviral pharmaceutical compositions containing alpha,alpha-dialkyl-adamantylamines
PH19980A (en) Benzenesulfonic esters of 2-uriidophenylthioureas,guanidines and substituted guanidines and pharmaceutical compositions containing them
GB1195319A (en) Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines
GB1174988A (en) Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same
GB943071A (en) Pharmaceutical compositions having appetite reducing properties
GB1442619A (en) 3-phenoxypropylamine derivatives their preparation and use
DE3365954D1 (en) The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles
GB915038A (en) Pharmaceutical compositions comprising calcium sulphosuccinate
GB1287433A (en) Pharmaceutical compositions
SE312632B (en)
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof
GB1056200A (en) Hypotensive compositions containing hydrochlorothiazide
GB1417323A (en) Physiologically active xanthine compounds and compositions containing them
GB1530166A (en) Adenine derivatives
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
GB879882A (en) Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3:4-dihydro-1:2:4-benzothiadiazine-1:1-dioxide
GB1127748A (en) Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency
GB926784A (en) 2-(4-methylpiperazino)-ethyl-guanidine and process for its manufacture
GB1072344A (en) Medicated poultry composition
FR937028A (en) Alkaline detergent containing active oxygen